Which toxic gas is released from aluminium phosphide that causes systemic toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Aluminum Phosphide Poisoning: Comprehensive Answers

Q.1: Primary Toxic Agent

Aluminum phosphide produces systemic toxicity primarily after release of phosphine (Answer B). When aluminum phosphide contacts gastric acid or moisture, it rapidly releases phosphine gas (PH₃), which is the actual toxic agent responsible for the devastating clinical effects 1, 2, 3.

  • Mechanism: Phosphine gas is quickly absorbed through respiratory and digestive tracts and non-selectively blocks mitochondrial cytochrome c oxidase, inhibiting electron transfer and suppressing oxidative phosphorylation 4, 3
  • This leads to profound cellular hypoxia, severe metabolic dysfunction, and ATP depletion despite adequate tissue oxygen delivery
  • The other options (arsine, hydrogen cyanide, phosgene) are unrelated to aluminum phosphide toxicity

Q.2: Antidote Status

No proven specific antidote currently exists for aluminum phosphide poisoning (Answer D). This is the most critical fact clinicians must understand when managing these cases 5, 2, 3.

  • Despite extensive research efforts in vitro and clinical models, no specific antidote has been validated 3
  • Hydroxocobalamin is used for cyanide poisoning (not aluminum phosphide)
  • Atropine is for organophosphate/cholinergic toxicity
  • Sodium thiosulfate is for cyanide poisoning
  • Management is entirely supportive, focusing on aggressive hemodynamic support, correction of metabolic derangements, and organ system support 5, 2

Q.3: Magnesium Sulfate Role

Evidence for routine high-dose magnesium is inconsistent; electrolyte abnormalities should be corrected (Answer C). This represents the most accurate, evidence-based statement about magnesium use in aluminum phosphide poisoning.

Key Points:

  • Magnesium sulfate is not a proven antidote and should not be administered indiscriminately to every patient 5
  • It does not reliably neutralize phosphine in the stomach—the gas is already released upon contact with gastric acid
  • Appropriate use: Magnesium should be given to correct documented hypomagnesemia and other electrolyte abnormalities that commonly occur 5, 2
  • It is not contraindicated—in fact, electrolyte repletion (including magnesium) is part of standard supportive care
  • The case report by 5 specifically mentions "repeated magnesium sulfate and electrolyte repletion" as part of successful management, but in the context of correcting deficiencies, not as primary antidotal therapy

Q.4: Poor Prognostic Indicators

Refractory shock + severe metabolic acidosis (Answer B) is most strongly associated with poor outcome in severe aluminum phosphide poisoning. This combination represents the hallmark of severe phosphine toxicity and predicts extremely high mortality 1, 2, 4.

Clinical Evidence:

  • Refractory cardiogenic shock is the primary cause of death, resulting from direct myocardial toxicity and profound mitochondrial dysfunction 2, 4
  • Severe metabolic acidosis with markedly elevated lactate (often >10-25 mmol/L) indicates profound cellular hypoxia and mitochondrial failure 1, 2
  • The fatal case reported by 1 demonstrated pH 6.81 with lactate up to 25 mmol/L
  • These findings reflect phosphine's inhibition of cytochrome c oxidase, leading to anaerobic metabolism and lactic acidosis

Why Other Options Are Incorrect:

  • Hypertension is not typical (hypotension is the rule)
  • Respiratory alkalosis is not characteristic (metabolic acidosis dominates)
  • Bradycardia with metabolic alkalosis is not the typical presentation
  • Isolated transaminitis with normal lactate suggests mild toxicity, not poor prognosis

Q.5: Zinc Phosphide Mechanism

Zinc phosphide releases phosphine after contact with gastric acid (Answer B). This is why zinc phosphide rodenticide poisoning clinically resembles aluminum phosphide poisoning 6, 3.

Mechanism:

  • Both aluminum phosphide and zinc phosphide are fumigant pesticides that release the same toxic agent: phosphine gas (PH₃)
  • Upon contact with gastric acid or moisture, both compounds undergo hydrolysis to release phosphine
  • The clinical presentation, toxicity mechanism, and management are essentially identical
  • Both cause mitochondrial dysfunction, refractory shock, metabolic acidosis, and multiorgan failure

Why Other Options Are Incorrect:

  • Vitamin K epoxide reductase blockade = warfarin/superwarfarin rodenticides
  • Acetylcholinesterase inhibition = organophosphate pesticides
  • Methemoglobinemia = nitrites, aniline dyes, dapsone (not phosphides)

Critical Management Pearls

Immediate Recognition:

  • High index of suspicion with history of pesticide exposure, especially in agricultural or fumigation settings
  • Rapid onset of hypotension, tachycardia, vomiting, and metabolic acidosis within hours of exposure 5, 2

Laboratory Hallmarks:

  • Severe metabolic acidosis (pH often <7.0)
  • Markedly elevated lactate (>10 mmol/L indicates severe toxicity)
  • Elevated troponin, transaminases, creatinine
  • Electrolyte abnormalities (hypocalcemia, hypokalemia, hypomagnesemia)
  • Coagulopathy/DIC in severe cases 1

Supportive Management Strategy:

  1. Ultra-early decontamination: Gastric lavage with liquid paraffin if presenting within 1-2 hours 2
  2. Aggressive hemodynamic support: High-dose vasopressors, inotropes, aggressive fluid resuscitation
  3. Metabolic correction: Aggressive correction of acidosis, electrolyte repletion (including magnesium)
  4. Organ support: Mechanical ventilation, continuous renal replacement therapy (CRRT), hemoperfusion 2, 4
  5. Arrhythmia management: Amiodarone preferred over beta-blockers (avoid negative inotropy) 5
  6. Consider ECMO: For refractory cardiogenic shock with cardiac arrest or severe ventricular dysfunction 4
  7. Corticosteroids: Often used empirically, though evidence is limited 5, 2

Prognosis:

  • Mortality approaches 100% in severe cases without aggressive intervention
  • Even massive ingestions (16× lethal dose) can be survived with timely, comprehensive critical care 2
  • Full recovery without sequelae is possible if the patient survives the acute phase 5, 2
  • Cardiac dysfunction and arrhythmias are typically reversible with appropriate support 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.